Word

ENHOPMA

Status

Pending

Status Code

686

Status Date

Tuesday, March 19, 2024

Serial Number

79366725

Mark Type

4000

Filing Date

Monday, March 6, 2023

Published for Opposition

Tuesday, March 12, 2024

Trademark Owner History

CELLTRION, INC. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of pain, of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases

Trademark Events

Mar 19, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 19, 2024

Published For Opposition

Feb 28, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 28, 2024

Notification Of Notice Of Publication E-Mailed

Feb 2, 2024

Withdrawn From Pub - Managing Attorney Request

Jan 31, 2024

Approved For Pub - Principal Register

Jan 24, 2024

Teas/Email Correspondence Entered

Jan 23, 2024

Correspondence Received In Law Office

Jan 23, 2024

Teas Response To Office Action Received

Jan 2, 2024

Refusal Processed By Ib

Dec 13, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Dec 13, 2023

Refusal Processed By Mpu

Dec 6, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Dec 5, 2023

Non-Final Action Written

Dec 4, 2023

Assigned To Examiner

Apr 11, 2023

Application Filing Receipt Mailed

Apr 7, 2023

New Application Office Supplied Data Entered

Apr 6, 2023

Sn Assigned For Sect 66a Appl From Ib